Introduction: Management of pancreatic incidentalomas(PI) is challenging due to high risk of malignancy and limitations in prediction of their histology and biological behavior. IPAS is one of such lesions and is often misdiagnosed as a PNET.
Aim(s): Case: A 65-year-old male presented with PI of 1.6, 1.3 cm suspected for IPAS on CT but finally misdiagnosed as a nonfunctioning PNET. Post-surgical histopathology identified lesions as IPAS.
Materials and methods: Literature review.
Conference: 9th Annual ENETS Conference (2012)
Presenting Author: Dr Esther Osher
, Klauzner J
, Greenman,Tordjman Y
, Scapa E
, Melhem A
, Ben-Haim M
, Nachmany I
, Shacham-Shmueli E
, Stern N
, Santo E
To read results and conclusion, please login ...
Further abstracts you may be interested in
Introduction: Neuroendocrine tumors of pancreas (PNET) are classified as functional or nonfunctional (NF) based on presence or absence of clinical syndrome associated with hormone over secretion. NF-PNETs do, however, often produce low levels of inactive hormones (pancreatic polypeptide, calcitonin or neurotensin) which do not cause any symptoms.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Dr Etyy Osher
Introduction: Activation of VEGFR2 and MET is implicated in driving growth of NET. Cabozantinib inhibits VEGFR2, MET, AXL, RET.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Medical treatment -Targeted therapies
Presenting Author: Jennifer Chan